Larson Financial Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.13K Hold
31
– – ﹤0.01% 2608
2026
Q2
$8.94K Buy
+31
New +$5.93K ﹤0.01% 2473

Other funds holding LABU

Larson Financial Group's LABU Position: Q3 2026 in Review

Larson Financial Group held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q3 2026 at 31 shares worth $8.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Larson Financial Group first reported a position in LABU in Q2 2026 and has held it in 2 quarters since. The position peaked at $8.94K in Q2 2026. 38 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

  • Larson Financial Group held 31 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $8.13K as of Q3 2026.
  • Larson Financial Group left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q3 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2608 holding.
  • Larson Financial Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2026 and has held it in 2 quarters since.
  • Larson Financial Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $8.94K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.